USD 18.2
(-5.41%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 6.6 Billion USD | 0.27% |
2022 | 6.58 Billion USD | 0.19% |
2021 | 6.57 Billion USD | -4.39% |
2020 | 6.87 Billion USD | 11.65% |
2019 | 6.15 Billion USD | 5.42% |
2018 | 5.84 Billion USD | -2.52% |
2017 | 5.99 Billion USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 5.51 Billion USD | 1.34% |
2024 Q2 | 5.43 Billion USD | -17.06% |
2024 Q1 | 6.55 Billion USD | -0.74% |
2023 Q2 | 6.6 Billion USD | 0.49% |
2023 FY | 6.6 Billion USD | 0.27% |
2023 Q4 | 6.6 Billion USD | -1.18% |
2023 Q3 | 6.68 Billion USD | 1.16% |
2023 Q1 | 6.57 Billion USD | -0.18% |
2022 Q3 | 6.41 Billion USD | -0.76% |
2022 Q2 | 6.46 Billion USD | -1.69% |
2022 Q1 | 6.57 Billion USD | -0.03% |
2022 FY | 6.58 Billion USD | 0.19% |
2022 Q4 | 6.58 Billion USD | 2.73% |
2021 Q3 | 6.56 Billion USD | 1.25% |
2021 FY | 6.57 Billion USD | -4.39% |
2021 Q1 | 6.32 Billion USD | -8.06% |
2021 Q2 | 6.48 Billion USD | 2.52% |
2021 Q4 | 6.57 Billion USD | 0.19% |
2020 Q1 | 6.24 Billion USD | 1.34% |
2020 FY | 6.87 Billion USD | 11.65% |
2020 Q4 | 6.87 Billion USD | 4.09% |
2020 Q3 | 6.6 Billion USD | -0.89% |
2020 Q2 | 6.66 Billion USD | 6.8% |
2019 Q2 | 6 Billion USD | 0.46% |
2019 Q4 | 6.15 Billion USD | 0.65% |
2019 Q3 | 6.11 Billion USD | 1.82% |
2019 Q1 | 5.98 Billion USD | 2.4% |
2019 FY | 6.15 Billion USD | 5.42% |
2018 Q4 | 5.84 Billion USD | 0.0% |
2018 FY | 5.84 Billion USD | -2.52% |
2017 FY | 5.99 Billion USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Alcon Inc. | 29.6 Billion USD | 77.688% |
AptarGroup, Inc. | 4.45 Billion USD | -48.366% |
Baxter International Inc. | 28.27 Billion USD | 76.641% |
Becton, Dickinson and Company | 52.78 Billion USD | 87.486% |
Bausch + Lomb Corporation | 13.44 Billion USD | 50.862% |
Haemonetics Corporation | 2.19 Billion USD | -200.835% |
ResMed Inc. | 6.87 Billion USD | 3.889% |
Teleflex Incorporated | 7.53 Billion USD | 12.313% |
Warby Parker Inc. | 580.31 Million USD | -1038.198% |
West Pharmaceutical Services, Inc. | 3.82 Billion USD | -72.479% |